Fact CheckerSign in

NCT06309069Completed

Calcified Cerebral Embolism: a Descriptive Study in a Large Single Center Cohort

Source: ClinicalTrials.gov · Last updated 23 Jan 2026

Brief summary (registry, in English)

Calcified cerebral embolism (CCE) is a relatively rare but underdiagnosed cause of infarction. CCE diagnosis is made by CT. Radiological characteristics of CCE have been reported in small case series. The aim of this study was to describe clinical and radiological characteristics of CCE in a large number of patients, and to compare patients with different radiological CCE characteristics.

Status (registry)
Completed
Study type
Observational
Enrollment
79 (actual)
First submitted
26 Feb 2024
Start date
16 Apr 2024
Primary completion date
30 Nov 2024
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Diseases
Stroke
NCT number
NCT06309069

What you commit to

  • Study type: Observational
  • Participants enrolled: 79
  • From 16 Apr 2024 to the primary completion date, 30 Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient's refusal to use his/her data

Who the study is looking for

  • Patients with CEE treated with intravenous thrombolysis (IVT) between 2015 and 2020 managed at the CHU de Nîmes or Patients with TIA/stroke with ECC identified on CT between 12/2019 and 04/2023 managed at CHU de Nîmes

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Nîmes
Coordinator of this site? Confirm its status
NîmesFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.